{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:40Z","timestamp":1767134920545,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":89,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006119.pub2","type":"reference-entry","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T19:38:51Z","timestamp":1307475531000},"source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment"],"prefix":"10.1002","author":[{"given":"Fiona","family":"Kew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadra","family":"Galaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"key":"10.1002\/14651858.CD006119.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376 (9747)","author":"Rustin","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2008.04.030","article-title":"The role of regular physical examination in the detection of ovarian cancer recurrence","volume":"110","author":"Chan","year":"2008","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1438.2007.00826.x","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gadducci","year":"2007","journal-title":"International Journal of Cancer"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(07)70273-5","article-title":"Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations","volume":"8","author":"Goonewardene","year":"2007","journal-title":"Lancet Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB5|cit5","first-page":"47","article-title":"Role of computed abdominal tomography CAT scan in the follow up of ovarian tumors","volume":"4","author":"Maggino","year":"1983","journal-title":"European Journal of Gynaecological Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1525-1438.2001.01042.x","article-title":"A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study","volume":"11","author":"Olaitan","year":"2001","journal-title":"International Journal of Gynecological Cancer"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/oxfordjournals.annonc.a010602","article-title":"Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study","volume":"7","author":"Rustin","year":"1996","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006119.pub2-BIB8|cit8","unstructured":"Lanceley A A randomised study comparing satisfaction with follow up led by a trained cancer nurse versus conventional medical follow-up after primary treatment for ovarian cancer N0263172828"},{"key":"10.1002\/14651858.CD006119.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/annonc\/mdn073","article-title":"Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up","volume":"19 Suppl 2","author":"Aebi","year":"2008","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-8258(92)90216-6","article-title":"Clinical surveillance of gynecologic cancer patients","volume":"46","author":"Barnhill","year":"1992","journal-title":"Gynecological Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB11|cit11","first-page":"85","article-title":"Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma","volume":"153","author":"Barzen","year":"1990","journal-title":"R\u00f6Fo: Fortschritte auf dem Gebiete der R\u00f6ntgenstrahlen und der Nuklearmedizin"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/01443610050112084","article-title":"What are the factors associated with the follow-up preferences of women in long-term remission from gynaecological cancer?","volume":"20","author":"Bradley","year":"2000","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"5A","key":"10.1002\/14651858.CD006119.pub2-BIB14|cit14","first-page":"1353","article-title":"CA-125 monitoring in the management of ovarian cancer","volume":"10","author":"Bruzzone","year":"1990","journal-title":"Anticancer Research"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB15|cit15","first-page":"347","article-title":"Validity of Gynaegnost in the follow-up of patients treated for ovarian cancer","volume":"84","author":"Cerejeira","year":"1989","journal-title":"Revue fran\u00e7aise de gyn\u00e9cologie et d'obst\u00e9trique"},{"key":"10.1002\/14651858.CD006119.pub2-BIB16|cit16","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration 2008 www.cochrane handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"1-2","key":"10.1002\/14651858.CD006119.pub2-BIB17|cit17","first-page":"135","article-title":"Clinical significance of cancer antigen 125 CA 125 in ovarian cancer","volume":"8","author":"Crombach","year":"1985","journal-title":"Cancer Detection and Prevention"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2214\/ajr.176.3.1760701","article-title":"Role of chest CT in the follow-up of ovarian adenocarcinoma","volume":"176","author":"Dachman","year":"2001","journal-title":"American Journal of Roentgenology"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/02841869509127187","article-title":"The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer","volume":"34","author":"Engblom","year":"1995","journal-title":"Acta Oncologica (Stockholm Sweden)"},{"key":"10.1002\/14651858.CD006119.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary","volume":"14 Suppl 5","author":"Sant","year":"2003","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1155\/1998\/738321","article-title":"The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer","volume":"14","author":"Fayed","year":"1998","journal-title":"Disease Markers"},{"issue":"3A","key":"10.1002\/14651858.CD006119.pub2-BIB22|cit22","first-page":"1551","article-title":"Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients","volume":"25","author":"Fehm","year":"2005","journal-title":"Anticancer Research"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-8258(92)90031-D","article-title":"The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients","volume":"44","author":"Fioretti","year":"1992","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jcp.42.1.40","article-title":"Serum placental-like alkaline phosphatase PLAP: a novel combined enzyme linked immunoassay for monitoring ovarian cancer","volume":"42","author":"Fisken","year":"1989","journal-title":"Journal of Clinical Pathology"},{"issue":"6B","key":"10.1002\/14651858.CD006119.pub2-BIB25|cit25","first-page":"2683","article-title":"The measurement of plasma D-dimer DD levels in the follow-up of patients with ovarian cancer","volume":"15","author":"Gadducci","year":"1995","journal-title":"Anticancer Research"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub2-BIB26|cit26","first-page":"320","article-title":"Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 724, SCC, 90 K","volume":"112","author":"Garzetti","year":"1991","journal-title":"Annali di Ostetricia Ginecologia Medicina Perinatale"},{"key":"10.1002\/14651858.CD006119.pub2-BIB27|cit27","unstructured":"Ferlay J Bray F Pisani P Parkin DM GLOBOCAN 2002.\u00a0 Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0.\u00a0 IARCPress, Lyon 2004"},{"issue":"10","key":"10.1002\/14651858.CD006119.pub2-BIB28|cit28","first-page":"746","article-title":"The value of FDG PET\/CT, ultrasound and CT in diagnosing recurrent ovarian carcinoma","volume":"77","author":"Grabiec","year":"2006","journal-title":"Ginekologia Polska"},{"key":"10.1002\/14651858.CD006119.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB30|cit30","first-page":"171","article-title":"Abdominal computerized tomography in the after-care of ovarian cancers","volume":"6","author":"Gritzmann","year":"1986","journal-title":"Digitale Bilddiagnostik"},{"key":"10.1002\/14651858.CD006119.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.313.7058.665","article-title":"Routine follow up of breast cancer in primary care: randomised trial","volume":"313","author":"Grunfeld","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejrad.2005.04.006","article-title":"Evaluation of integrated whole-body PET\/CT in the detection of recurrent ovarian cancer","volume":"56","author":"Hauth","year":"2005","journal-title":"European Journal of Radiology"},{"issue":"1-2","key":"10.1002\/14651858.CD006119.pub2-BIB33|cit33","first-page":"263","article-title":"Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer","volume":"6","author":"Hetzel","year":"1983","journal-title":"Cancer Detection and Prevention"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00000421-199104000-00003","article-title":"Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients","volume":"14","author":"Hising","year":"1991","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006119.pub2-BIB35|cit35","article-title":"Cancer Incidence in Five Continents, Volume VIII","volume-title":"IARC Scientific Publication No. 155","author":"Parkin","year":"2002"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub2-BIB36|cit36","first-page":"1799","article-title":"Tissue polypeptide antigen as a tumor marker for gynecologic malignancies","volume":"37","author":"Inoue","year":"1985","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB37|cit37","first-page":"1256","article-title":"Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels","volume":"24","author":"Iwanari","year":"1989","journal-title":"Nippon Gan Chiryo Gakkai Shi"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jacr.2007.05.019","article-title":"ACR Appropriateness criteria on staging and follow-up of ovarian cancer","volume":"4","author":"Javitt","year":"2007","journal-title":"Journal of the American College of Radiology"},{"key":"10.1002\/14651858.CD006119.pub2-BIB39|cit39","first-page":"71","article-title":"Cancer Statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"17","key":"10.1002\/14651858.CD006119.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF01732187","article-title":"Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer CA 125 as a tumor marker A cooperative study of the Gynecologic Tumor Marker Group GTMG","volume":"64","author":"Kaesemann","year":"1986","journal-title":"Klinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1479-828X.1995.tb01986.x","article-title":"Follow-up of patients with gynaecological cancer","volume":"35","author":"Kerr-Wilson","year":"1995","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1525-1438.2005.15302.x","article-title":"The role of routine follow-up after gynecological malignancy","volume":"15","author":"Kew","year":"2005","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD006119.pub2-BIB43|cit43","doi-asserted-by":"crossref","unstructured":"Kew FM Cruickshank DJ Routine follow up after treatment for a gynaecological cancer: a survey of practice International Journal of Gynecological Cancer 2006 380 84","DOI":"10.1111\/j.1525-1438.2006.00421.x"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.159.1.3513245","article-title":"Ovarian carcinoma follow-up: US versus laparotomy","volume":"159","author":"Khan","year":"1986","journal-title":"Radiology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/1097-0142(197409)34:3<542::AID-CNCR2820340311>3.0.CO;2-K","article-title":"Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term followup of female genital cancer","volume":"34","author":"Khoo","year":"1974","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(197906)43:6<2471::AID-CNCR2820430644>3.0.CO;2-E","article-title":"Predictive value of serial carcinoembryonic antigen levels in long- term follow-up of ovarian cancer","volume":"43","author":"Khoo","year":"1979","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/rct.0b013e31803e8c45","article-title":"Detection of recurrent ovarian cancer at MRI: comparison with integrated PET\/CT","volume":"31","author":"Kim","year":"2007","journal-title":"Journal of Computer Assisted Tomography"},{"issue":"8","key":"10.1002\/14651858.CD006119.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00259-008-0776-3","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET\/non-contrast-enhanced CT and enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB49|cit49","first-page":"15","article-title":"Clinical usefulness of serum sialyl Lex-i measurement in patients with ovarian cancer","volume":"41","author":"Kobayashi","year":"1989","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s003300051000","article-title":"Value of 18F-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma","volume":"10","author":"Kubik-Huch","year":"2000","journal-title":"European Radiology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0936-6555(05)81037-4","article-title":"The value of follow-up in stage II carcinoma of the cervix","volume":"3","author":"Kunkler","year":"1991","journal-title":"Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD006119.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/1097-0142(19871101)60:9<2228::AID-CNCR2820600921>3.0.CO;2-N","article-title":"The predictive value of a combination of tumor markers in monitoring patients with ovarian cancer","volume":"60","author":"Lahousen","year":"1987","journal-title":"Cancer"},{"issue":"5-6","key":"10.1002\/14651858.CD006119.pub2-BIB53|cit53","first-page":"389","article-title":"Clinical correlations of carcinoembryonic antigen in post-operative patients with epithelial ovarian cancer","volume":"7","author":"Lenehan","year":"1986","journal-title":"Tumour Biology"},{"issue":"4C","key":"10.1002\/14651858.CD006119.pub2-BIB54|cit54","first-page":"2303","article-title":"PET-CT in recurrent ovarian cancer: impact on treatment planning","volume":"28","author":"Lenhard","year":"2008","journal-title":"Anticancer Research"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/radiology.211.2.r99ma24519","article-title":"Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination--a longitudinal study","volume":"211","author":"Low","year":"1999","journal-title":"Radiology"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00259-006-0306-0","article-title":"Integrated PET\/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer","volume":"34","author":"Mangili","year":"2007","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2006.02.005","article-title":"Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels","volume":"103","author":"Menczer","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD006119.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.325.7373.1145","article-title":"Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial","volume":"325","author":"Moore","year":"2002","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/ajr.176.6.1761449","article-title":"Clinical value of positron emission tomography with FDG for recurrent ovarian cancer","volume":"176","author":"Nakamoto","year":"2001","journal-title":"American Journal of Roentgenology"},{"issue":"4A","key":"10.1002\/14651858.CD006119.pub2-BIB60|cit60","first-page":"2513","article-title":"CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer","volume":"19","author":"Oehler","year":"1999","journal-title":"Anticancer Research"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB61|cit61","first-page":"363","article-title":"Assessment of ovarian tumors by transvaginal scanning and clinical significance of ultrasonic examination in postoperative follow up","volume":"40","author":"Okai","year":"1992","journal-title":"Rinsho Byori. The Japanese Journal of Clinical Pathology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2005.11.046","article-title":"A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference","volume":"101","author":"Palmer","year":"2006","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2005.08.057","article-title":"The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer","volume":"100","author":"Parker","year":"2006","journal-title":"Gynecologic Oncology"},{"issue":"24","key":"10.1002\/14651858.CD006119.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints [Erratum appears in Statistics in Medicine 2004 Jun 15;23(11):1817]","volume":"17","author":"Parmar","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00004728-199307000-00021","article-title":"CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer","volume":"17","author":"Prayer","year":"1993","journal-title":"Journal of Computer Assisted Tomography"},{"key":"10.1002\/14651858.CD006119.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.324.7341.813","article-title":"Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials","volume":"324","author":"Renehan","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.bjc.6602369","article-title":"Mechanisms of improved survival from intensive follow up in colorectal cancer: a hypothesis","volume":"92","author":"Renehan","year":"2005","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"353-66","DOI":"10.1080\/13698570903013623","article-title":"Future disorientation following gynaecological cancer: Women\u2019sconceptualisation of risk after a life threatening illness","volume":"11","author":"Roberts","year":"2009","journal-title":"Health, Risk & Society"},{"issue":"9021","key":"10.1002\/14651858.CD006119.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(05)66133-8","article-title":"Use of CA 125 in follow-up of ovarian cancer","volume":"348","author":"Rustin","year":"1996","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD006119.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1158\/1078-0432.CCR-03-0365","article-title":"Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer","volume":"10","author":"Schorge","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2214\/ajr.177.4.1770857","article-title":"Value of chest CT scans in routine ovarian carcinoma follow-up","volume":"177","author":"Sella","year":"2001","journal-title":"American Journal of Roentgenology"},{"issue":"4","key":"10.1002\/14651858.CD006119.pub2-BIB72|cit72","first-page":"554","article-title":"Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects","volume":"38","author":"Shimizu","year":"1986","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"1-2","key":"10.1002\/14651858.CD006119.pub2-BIB73|cit73","first-page":"53","article-title":"Follow-up laparoscopy in patients with ovarian cancer","volume":"19","author":"Shinozuka","year":"1994","journal-title":"The Tokai Journal of Experimental and Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB74|cit74","first-page":"1127","article-title":"Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer","volume":"15","author":"Sliutz","year":"1995","journal-title":"Anticancer Research"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub2-BIB75|cit75","first-page":"5","article-title":"The views of ovarian cancer survivors on its cause, prevention, and recurrence","volume":"6","author":"Stewart","year":"2001","journal-title":"Medscape Women's Health"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB76|cit76","first-page":"213","article-title":"Feasibility of peritoneal washing cytology through the totally implanted reservoir for early detection of peritoneal recurrence of ovarian cancer","volume":"48","author":"Sugiyama","year":"1996","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1097-0215(19980619)79:3<241::AID-IJC5>3.0.CO;2-P","article-title":"Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients","volume":"79","author":"Tempfer","year":"1998","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD006119.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1469-0705.2002.00693.x","article-title":"Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy","volume":"19","author":"Testa","year":"2002","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ygyno.2005.07.116","article-title":"The role of sonographic examination in the follow-up of gynecological neoplasms","volume":"99","author":"Testa","year":"2005","journal-title":"Gynecologic oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","article-title":"Clinical use of combined positron emission tomography and computed tomography FDG-PET\/CT in recurrent ovarian cancer","volume":"105","author":"Thrall","year":"2007","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00259-001-0750-9","article-title":"Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy- D-glucose","volume":"29","author":"Torizuka","year":"2002","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3 pt2","key":"10.1002\/14651858.CD006119.pub2-BIB82|cit82","first-page":"S1","article-title":"The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up","volume":"55","author":"Trimble","year":"1994","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/003655102317475434","article-title":"Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up","volume":"62","author":"Tuxen","year":"2002","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"3","key":"10.1002\/14651858.CD006119.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0093-7754(03)00100-3","article-title":"The follow-up of ovarian cancer","volume":"30","author":"Vaidya","year":"2003","journal-title":"Seminars in Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006119.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0090-8258(80)90064-5","article-title":"Follow-up study of ovarian carcinoma by cytology of cul-de-sac aspirates","volume":"10","author":"VillaSanta","year":"1980","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB86|cit86","first-page":"205","article-title":"Tumor marker CA 125 in diagnosis, monitoring management and follow-up of patients with ovarian tumors","volume":"13","author":"Vinokurov","year":"1992","journal-title":"European Journal of Gynaecological Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB87|cit87","first-page":"1015","article-title":"Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma","volume":"27","author":"Vuento","year":"2007","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1002\/14651858.CD006119.pub2-BIB88|cit88","first-page":"356","article-title":"Role of positron emission tomography in detecting recurrent epithelial ovarian carcinoma","volume":"37","author":"Zhu","year":"2002","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"2","key":"10.1002\/14651858.CD006119.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/gyno.2001.6386","article-title":"2-Fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer","volume":"83","author":"Zimny","year":"2001","journal-title":"Gynecologic Oncology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006119.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:00:00Z","timestamp":1410134400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006119.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:55:18Z","timestamp":1628531718000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006119.pub2"}},"subtitle":[],"editor":[{"given":"Fiona","family":"Kew","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":89,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006119.pub2","relation":{},"subject":[],"published":{"date-parts":[[2011,6,15]]}}}